Business Context and Reporting Period
Company: Dr. Reddy's Laboratories Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Quarter and fiscal year ended March 31, 2019
Filing Date: May 17, 2019
This filing serves as a disclosure of results of operations and financial condition. The company announced its financial results under International Financial Reporting Standards (IFRS) and Indian Accounting Standards (Ind AS) via a press release and attached exhibits.
Key Financial Metrics
Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached exhibits (Exhibits 99.1 through 99.4) which are referenced but not included in the text of this Form 6-K.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release and financial statements for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The text does not include specific management commentary, forward-looking guidance, or risk factors. It solely confirms the release of audited financial results.
Unusual Items: No unusual items are described in the text of this filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for the summary of Q4 and FY19 performance.
- Examine Exhibit 99.2 for detailed IFRS Audited Consolidated Financial Results.
- Examine Exhibit 99.3 for detailed Ind AS Audited Consolidated Financial Results.
- Verify standalone financial performance via Exhibit 99.4 (Ind AS Audited Standalone Financial Results).
- Confirm the specific numerical values for revenue growth, net profit, and cash flow positions which are absent from this cover document.